Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
Rotavirus
2021
Americas
Clear all
Type of publications
NITAG documentation
(61)
Systematic reviews (SYSVAC)
(9)
Topics
Available to download in languages
Regions
Americas
(70)
Africa
(22)
Europe
(78)
South-East Asia
(3)
Western Pacific
(15)
Countries
Argentina
(1)
Bolivia
(2)
Canada
(16)
Chile
(9)
Mexico
(1)
United States of America
(40)
Diseases
COVID-19
(64)
Human papillomavirus (HPV)
(4)
Rotavirus
(2)
Ebola
(1)
Meningococcal disease
(1)
Vaccine topics
Acceptance
(4)
Administration
(1)
Coverage
(5)
Efficacy/effectiveness
(1)
Ethical issues
(4)
Safety
(1)
Target population
Adolescents
(4)
Adults
(5)
All age groups
(2)
Children
(5)
Healthcare workers
(1)
Newborn
(2)
Older adults
(1)
Parents/caregivers
(2)
Pregnant women
(4)
Publication date
2021
(70)
2024
(1)
2023
(12)
2022
(47)
2020
(65)
2019
(9)
2018
(10)
2017
(5)
2016
(16)
2015
(10)
2014
(10)
2013
(3)
2012
(1)
2011
(2)
2010
(4)
2009
(3)
2008
(4)
2007
(1)
70 results found
2021
∙
ACIP
ACIP Evidence to Recommendations for Use of Janssen COVID-19 Vaccine under an Emergency Use Authorization
2021
∙
ACIP
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years - May 12, 2021
2021
∙
ACIP
ACIP Updated Recommendations for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - 27 April 2021
2021
∙
Sara Oliver, ACIP
ACIP Work Group interpretations of data
2021
∙
ACIP
AstraZeneca COVID-19 vaccine (AZD1222)
2021
∙
CAVEI
CAVEI ordinary meeting December 29th 2021
2021
∙
CAVEI
CAVEI recommendation for the prioritization of COVID-19 vaccination in adolescents aged 12 to 17 years - 15 June 2021
2021
∙
CAVEI
CAVEI recommendation on the introduction of a booster dose to the COVID-19 Vaccination Plan - 29 July 2021
2021
∙
CAVEI
CAVEI recommendations for the use of the AstraZeneca COVID-19 vaccine - 5 June 2021
2021
∙
CAVEI
CAVEI's recommendation on the use of COVID-19 vaccines and other programmatic vaccines or vaccination campaigns
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register